메뉴 건너뛰기




Volumn 79, Issue 3, 2009, Pages 137-142

Selective internal radiotherapy with yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: A prospective single center study

Author keywords

Liver metastases; Neuroendocrine tumors; Radioembolization; Selective internal radiation therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; MACROSALB TC 99M; MICROSPHERE; YTTRIUM 90;

EID: 62649150203     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209849     Document Type: Article
Times cited : (103)

References (29)
  • 1
    • 0028323620 scopus 로고    scopus 로고
    • Gastrointestinal neuroendocrine tumors
    • Delcore R, Friesen SR: Gastrointestinal neuroendocrine tumors. J Am Coll Surg 2004; 178: 188-211.
    • (2004) J Am Coll Surg , vol.178 , pp. 188-211
    • Delcore, R.1    Friesen, S.R.2
  • 3
    • 2942675021 scopus 로고    scopus 로고
    • The diagnosis and medical management of advanced neuroendocrine tumors
    • Kaltsas GA, Besser GM, Grossman AB: The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25: 458-511.
    • (2004) Endocr Rev , vol.25 , pp. 458-511
    • Kaltsas, G.A.1    Besser, G.M.2    Grossman, A.B.3
  • 4
    • 18844422974 scopus 로고    scopus 로고
    • Current status of gastrointestinal carcinoids
    • Modlin IM, Kidd M, Latich I, et al: Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717-1751.
    • (2005) Gastroenterology , vol.128 , pp. 1717-1751
    • Modlin, I.M.1    Kidd, M.2    Latich, I.3
  • 6
    • 0037441624 scopus 로고    scopus 로고
    • A 5-decade analysis of 13,715 carcinoid tumors
    • Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959.
    • (2003) Cancer , vol.97 , pp. 934-959
    • Modlin, I.M.1    Lye, K.D.2    Kidd, M.3
  • 7
    • 24644503671 scopus 로고    scopus 로고
    • Phase II/III study of doxorubicin with fluorouracil compared with streptozo- cin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281
    • Sun W, Llpsitz S, Catalano P, Maillard JA, Haller DA: Phase II/III study of doxorubicin with fluorouracil compared with streptozo- cin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 2005; 23: 4897-4904.
    • (2005) J Clin Oncol , vol.23 , pp. 4897-4904
    • Sun, W.1    Llpsitz, S.2    Catalano, P.3    Maillard, J.A.4    Haller, D.A.5
  • 8
    • 3442884868 scopus 로고    scopus 로고
    • Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
    • Oberg K, Kvols S, Caplin M, et al: Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004; 15: 966-973.
    • (2004) Ann Oncol , vol.15 , pp. 966-973
    • Oberg, K.1    Kvols, S.2    Caplin, M.3
  • 9
    • 0033847588 scopus 로고    scopus 로고
    • Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors
    • (suppl l)
    • Ruszniewski P, Malka D: Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 2000; 62(suppl l): 79-83.
    • (2000) Digestion , vol.62 , pp. 79-83
    • Ruszniewski, P.1    Malka, D.2
  • 10
    • 26444475764 scopus 로고    scopus 로고
    • Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival
    • Gupta S, Johnson MM, Murthy R, et al: Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005; 104: 1590-1602.
    • (2005) Cancer , vol.104 , pp. 1590-1602
    • Gupta, S.1    Johnson, M.M.2    Murthy, R.3
  • 11
    • 22244476442 scopus 로고    scopus 로고
    • Yttrium- 90 microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results
    • Murthy R, Xiong H, Nunez R, et al: Yttrium- 90 microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vase Interv Radiol 2005; 16: 937-945.
    • (2005) J Vase Interv Radiol , vol.16 , pp. 937-945
    • Murthy, R.1    Xiong, H.2    Nunez, R.3
  • 12
    • 33646237122 scopus 로고    scopus 로고
    • Resin 90Y microsphere brachytherapy for unresecatbale colorectal liver metastases: modern USA experience
    • Kennedy AS, Coldwell D, Nutting C, et al: Resin 90Y microsphere brachytherapy for unresecatbale colorectal liver metastases: modern USA experience. Int J Rad Oncol Biol Phys 2006; 65: 412-425.
    • (2006) Int J Rad Oncol Biol Phys , vol.65 , pp. 412-425
    • Kennedy, A.S.1    Coldwell, D.2    Nutting, C.3
  • 13
    • 28044465731 scopus 로고    scopus 로고
    • Yt- trium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications
    • (suppl 1)
    • Murthy R, Nunez R, Szklaruk J, et al: Yt- trium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 2005; 25(suppl 1): S41-S55.
    • (2005) Radiographics , vol.25
    • Murthy, R.1    Nunez, R.2    Szklaruk, J.3
  • 14
    • 0035700227 scopus 로고    scopus 로고
    • Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
    • Gray B, Van Hazel G, Hope M, et al: Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-1720.
    • (2001) Ann Oncol , vol.12 , pp. 1711-1720
    • Gray, B.1    Van Hazel, G.2    Hope, M.3
  • 15
    • 2442680770 scopus 로고    scopus 로고
    • Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients
    • (suppl 1)
    • Carr B: Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10(suppl 1): S107-S110.
    • (2004) Liver Transpl , vol.10
    • Carr B1
  • 17
    • 44949120870 scopus 로고    scopus 로고
    • Radioembolization for unresectable neuroendocrine hepatic metastases using resinY-microspheres: early results in 148 patients
    • Kennedy AS, Dezarn WA, McNeillie P, et al: Radioembolization for unresectable neuroendocrine hepatic metastases using resin Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008; 31: 271-279.
    • (2008) Am J Clin Oncol , vol.31 , pp. 271-279
    • Kennedy, A.S.1    Dezarn, W.A.2    McNeillie, P.3
  • 18
    • 52049109269 scopus 로고    scopus 로고
    • Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
    • King J, Quinn R, Glenn DM, et al: Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113: 921-929.
    • (2008) Cancer , vol.113 , pp. 921-929
    • King, J.1    Quinn, R.2    Glenn, D.M.3
  • 19
    • 57349083153 scopus 로고    scopus 로고
    • Resin 90Y microsphere brachytherapy for unresectable neuroendocrine hepatic metastases
    • suppl
    • Kennedy AS, Liu D, Dezarn AW, et al: Resin 90Y microsphere brachytherapy for unresectable neuroendocrine hepatic metastases. Am J Oncol Rev 2006; 4(suppl):l-8.
    • (2006) Am J Oncol Rev , vol.4
    • Kennedy, A.S.1    Liu, D.2    Dezarn, A.W.3
  • 20
    • 33747515562 scopus 로고    scopus 로고
    • Radioembolization with 90-yttrium microspheres: a state-of- the-art brachytherapy treatment for primary and secondary liver malignancies
    • Salem R, Thurston KG: Radioembolization with 90-yttrium microspheres: a state-of- the-art brachytherapy treatment for primary and secondary liver malignancies. 1. Technical and methodologic considerations. J Vase Interv Radiol 2006; 17: 1251-1278.
    • (2006) Technical and methodologic considerations. J Vase Interv Radiol , vol.17 , pp. 1251-1278
    • Salem, R.1    Thurston, K.G.2
  • 21
    • 3142662858 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors
    • Duffaud F, Therasse P: New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 2000; 87: 881-886.
    • (2000) Bull Cancer , vol.87 , pp. 881-886
    • Duffaud, F.1    Therasse, P.2
  • 22
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson NK, Ahmedzai S, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2
  • 23
    • 0038240915 scopus 로고    scopus 로고
    • Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer
    • Kavadas V, Blazeba JM, et al: Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 2003; 39: 1259-1263.
    • (2003) Eur J Cancer , vol.39 , pp. 1259-1263
    • Kavadas, V.1    Blazeba, J.M.2
  • 24
    • 33746702549 scopus 로고    scopus 로고
    • Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy
    • Veenendaal LM, Borel Rinkes IH, Lips CJ, et al: Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol 2006; 4: 35-39.
    • (2006) World J Surg Oncol , vol.4 , pp. 35-39
    • Veenendaal, L.M.1    Borel Rinkes, I.H.2    Lips, C.J.3
  • 25
    • 33750087253 scopus 로고    scopus 로고
    • Metastatic neuroendocrine hepatic tumors: resec tion improves survival
    • Musunuru S, Chen H, Rajpal S, et al: Metastatic neuroendocrine hepatic tumors: resec tion improves survival. Arch Surg 2006; 141: 1000-1004.
    • (2006) Arch Surg , vol.141 , pp. 1000-1004
    • Musunuru, S.1    Chen, H.2    Rajpal, S.3
  • 26
    • 0346727160 scopus 로고    scopus 로고
    • Transar- terial chemoembolization of advanced liver metastases of neuroendocrine tumors: a retrospective single-centre analysis
    • Kress O, Wagner HJ, Wied M, et al: Transar- terial chemoembolization of advanced liver metastases of neuroendocrine tumors: a retrospective single-centre analysis. Digestion 2003; 68: 94-101.
    • (2003) Digestion , vol.68 , pp. 94-101
    • Kress, O.1    Wagner, H.J.2    Wied, M.3
  • 27
    • 0037645499 scopus 로고    scopus 로고
    • Trans- catheter arterial chemoembolization as first- line treatment for hepatic metastases from endocrine tumors
    • Roche A, Girish BV, de Baere T, et al: Trans- catheter arterial chemoembolization as first- line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003; 13: 136-140.
    • (2003) Eur Radiol , vol.13 , pp. 136-140
    • Roche, A.1    Girish, B.V.2    De Baere, T.3
  • 28
    • 34247581169 scopus 로고    scopus 로고
    • Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors
    • Ho AS, Picus J, Darcy MD, et al: Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 2007; 188: 1201-1207.
    • (2007) AJR Am J Roentgenol , vol.188 , pp. 1201-1207
    • Ho, A.S.1    Picus, J.2    Darcy, M.D.3
  • 29
    • 1242291142 scopus 로고    scopus 로고
    • Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-yttrfum microspheres (therasphere)
    • Steel J, Baum A, Carr B: Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-yttrfum microspheres (therasphere). Psychooncology 2004; 13: 73-79.
    • (2004) Psychooncology , vol.13 , pp. 73-79
    • Steel, J.1    Baum, A.2    Carr, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.